Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.
about
Blood alpha-synuclein in agricultural pesticide handlers in central Washington StateModeling Parkinson's disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal careEmerging candidate biomarkers for Parkinson's disease: a reviewPlasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotypeAlpha-Synuclein in Parkinson's Disease: From Pathogenetic Dysfunction to Potential Clinical ApplicationDecrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interferenceDJ-1 isoforms in whole blood as potential biomarkers of Parkinson diseaseDifferentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.Targeted discovery and validation of plasma biomarkers of Parkinson's disease.Towards translational therapies for multiple system atrophyBlood-based biomarkers for Parkinson's diseaseα-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controlsNaturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.Using gastrocnemius sEMG and plasma α-synuclein for the prediction of freezing of gait in Parkinson's disease patients.Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition.Alpha-synuclein levels in blood plasma decline with healthy aging.Serological Analysis of Alpha-synuclein and NF-κB in Parkinson's Disease Patients.Premotor biomarkers for Parkinson's disease - a promising direction of research.Altered Plasma Profile of Antioxidant Proteins as an Early Correlate of Pancreatic β Cell Dysfunction.Alpha-Synuclein Expression in Patients with Parkinson's Disease: A Clinician's Perspective.Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles.Up-regulation of SNCA gene expression: implications to synucleinopathiesSalivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patientsA longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease.Dataset of total, oligomeric alpha-synuclein and hemoglobin levels in plasma in Parkinson׳s disease.α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease.Parkinson's disease--the continuing search for biomarkers.Biomarkers of Parkinson's disease: current status and future perspectives.New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications.Role of platelets in neurodegenerative diseases: a universal pathophysiology.Gender differences in Parkinson's disease: focus on plasma α-synuclein.Cerebrospinal fluid biomarker candidates for parkinsonian disorders.α-Synuclein and mitochondrial dysfunction in Parkinson's disease.Is there a need to redefine Parkinson's disease?New insight into neurodegeneration: the role of proteomics.Oxidized DJ-1 as a possible biomarker of Parkinson's diseaseSalivary proteomics and biomarkers in neurology and psychiatry.The Concept of Prodromal Parkinson's Disease.
P2860
Q23922069-E54D7487-BEAC-4E54-92A8-21049DD9852EQ26772285-11E97061-07A1-4394-A76B-B2ABC97DC552Q27015018-B2E8563A-A84C-43D2-B7D6-04D3B72CCE6CQ27322563-A91142E3-F64E-477F-85F2-2818ED464E8CQ27333275-0E63609B-EF3A-41ED-8FA5-817C96512D2AQ28079911-D8C79467-6647-43DF-96A1-905816D5C48FQ28545821-9C5E02A2-C9B4-4747-AB77-DC57018CADF0Q30529658-08BE9B3C-BE8A-4CDD-86B3-EDCA28FDFD94Q30588544-04E663E5-F9CD-4307-86B5-43B64C61DDB1Q30597182-F2A713FF-EEAA-4355-A2DB-FF18B4927D50Q33797532-7DBCE57F-FCC8-4A62-984A-E8BBC9A400D4Q33804255-5396724D-FFBF-417B-9529-DC30FDCAE421Q34533573-1BE60821-D123-4BF2-9A5E-32426D61EB6AQ34627859-DD1DC199-5AAD-4B05-A039-690A6A59D409Q35107114-13FDDB07-5B95-4E48-9AD2-EFBAB1FA6306Q35139572-984F6045-B33A-4AE3-82AB-1C5772B89133Q35174085-FF407224-C5A2-4162-8274-7390576212C5Q35284843-F1FE4D31-C078-4839-AFCA-FBDF0ED3C9EEQ35792286-D6CFE0C3-ECD5-474C-B892-4B0CD872B9F1Q36444517-011F06D0-DAF2-4334-82FB-0FD14C6D851DQ36850046-C193DAC6-8CB4-427B-95F3-91998FB463D6Q36976868-D2C943FA-C392-461E-BC7E-49B7AE3CC448Q36982173-D763E15D-B0AB-4FD3-98FA-D09590FBBB2AQ37004246-9E661CEC-716A-4C4F-ADF8-5A68A52ED5CEQ37030864-28A885A8-9BF9-4476-9B0F-E695961D91FDQ37129697-E1E872BC-FFAE-4DBD-B4BA-1301F36F02CAQ37491380-2D1B225A-35EA-4F2A-9203-94432612FA5FQ37820120-F31BA663-6BF8-42C2-B4D8-F5EBF4DAA251Q37834648-2B6B6623-6B15-48FC-8835-D085EC935C0CQ38043841-B49043EB-25D3-4BC2-A407-EA5903A1DD39Q38067141-2076CB6E-497E-40CA-A74A-F3FE9196EA26Q38072757-1AD95FB7-6A94-48EB-88C2-EB192B7FAABFQ38074839-0F63430C-D766-4ED3-AE2C-A1B95CEEBC26Q38076411-EE64B1DD-C8D1-4F4F-9BF9-E9A260F7C0A3Q38077665-9A479E26-35E2-4875-822A-B8EAD8A527ACQ38110209-00568C97-FB03-4675-87B0-A5040C0520E4Q38170010-FA31C77A-BDE8-46D0-80DB-0F07E752A0F3Q38217361-E3E958B2-569E-471A-8EC1-E6EB490F51EBQ38335930-63511EA0-5D29-4FD6-B1A1-C71BA3111BBAQ38612230-DD6A4A19-6AC4-4C08-BB1D-74222D976F85
P2860
Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Significance and confounders o ...... uclein in Parkinson's disease.
@ast
Significance and confounders o ...... uclein in Parkinson's disease.
@en
type
label
Significance and confounders o ...... uclein in Parkinson's disease.
@ast
Significance and confounders o ...... uclein in Parkinson's disease.
@en
prefLabel
Significance and confounders o ...... uclein in Parkinson's disease.
@ast
Significance and confounders o ...... uclein in Parkinson's disease.
@en
P2093
P2860
P50
P1433
P1476
Significance and confounders o ...... nuclein in Parkinson's disease
@en
P2093
Aneeka M Hancock
Carmen Ginghina
Dora Yearout
Douglas Galasko
Elaine R Peskind
Jing Zhang
Joseph Jankovic
Kathryn A Chung
P2860
P356
10.1016/J.NEULET.2010.06.009
P407
P577
2010-06-09T00:00:00Z